Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • V vs MRNA✓SelectedUSD · MRNAV vs MRNA performance historyLatest closeAs of-3.12%11/19
Stock and ETF performance explorer

V vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+210.5%
MRNA return
+806.0%
Excess return
-595.6%
Maximum drawdown
-36.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.1%+1.3%-4.4%-3.2%
7D-4.3%-13.8%+9.5%-4.0%
30D-0.9%-17.7%+16.8%-0.6%
3M+10.2%+14.3%-4.1%+9.7%
6M+22.4%+336.0%-313.6%+16.0%
YTD+15.6%+575.9%-560.3%+7.4%
1Y+25.1%+724.4%-699.3%+15.3%
3Y+64.9%+160.8%-95.9%+55.4%
5Y+108.0%-24.4%+132.4%+97.9%
All+210.5%+806.0%-595.6%+194.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling